Researchers at the University of Kentucky are testing the effectiveness of a vaccine that may be able to treat pancreatic cancer.
Sep 4, 2024
0
1
Two recent scientific papers about optimal treatment of older patients with cancer not only improve clinical care but also demonstrate Wilmot Cancer Institute's international leadership in this growing field.
Sep 4, 2024
0
0
A new review was published in Oncotarget on August 2, 2024, entitled, "Targeting WNT5B and WNT10B in osteosarcoma."
Sep 4, 2024
0
0
A University of Alberta research team has found a potential new treatment target for ovarian cancer. Their new research is the first to comprehensively investigate the elevated expression of a gene called ZIC2 in ovarian ...
Sep 3, 2024
0
73
Leiden researchers have developed a model to advance cancer immunotherapy. Using a 3D printer, they create mini-tumors within an environment that closely mimics human tissue. They have also developed a method to monitor real-time ...
Sep 3, 2024
0
51
In a study using human breast cancer cells, scientists say they have potentially identified immune system white blood cells that appear to be the closest neighbors of breast cancer cells that are likely to spread. The researchers ...
Sep 3, 2024
0
28
A new study from researchers with the Advanced Science Research Center at the CUNY Graduate Center (CUNY ASRC) sheds light on why certain oligodendrocyte progenitor cells (OPCs) in the adult brain transform into gliomas, ...
Sep 3, 2024
0
19
For many doctors and researchers, immunotherapy that uses someone's own immune system to target and attack cancer cells is the next and best frontier of cancer treatment. Chimeric antigen receptor T-cell therapy, or CAR-T ...
Sep 3, 2024
0
1
Prostate cancer is the second most common cancer among men worldwide, following lung cancer. In the United States alone, nearly 300,000 new cases are diagnosed annually. While reducing testosterone and other male hormones ...
Sep 3, 2024
0
0
Led by investigators of the Vall d'Hebron Institute of Oncology's (VHIO) Experimental Therapeutics Group, in collaboration with VHIO's Hereditary Cancer Genetics Group and the Medical Oncology Department at the Vall d'Hebron ...
Sep 3, 2024
0
1
